APD vs PPCB · P/E 30, rev $12.04B vs P/E 0.0, $3.9M cap
Air Products and Chemicals Inc (APD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
PPCB does not have a complete income-statement cache yet.
APD currently screens at market cap $62.74B and trailing P/E 29.7. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the APD and PPCB stock pages for the full models.
Not investment advice.